Delta Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$566K Buy
1,608
+2
+0.1% +$713 0.1% 134
2025
Q4
$526K Buy
1,606
+6
+0.4% +$1.9K 0.09% 154
2025
Q3
$452K Buy
1,600
+14
+0.9% +$4.06K 0.08% 152
2025
Q2
$443K Sell
1,586
-68
-4% -$19.3K 0.09% 148
2025
Q1
$515K Buy
1,654
+5
+0.3% +$1.48K 0.1% 121
2024
Q4
$430K Sell
1,649
-65
-4% -$19.3K 0.08% 144
2024
Q3
$552K Sell
1,714
-189
-10% -$61.8K 0.11% 111
2024
Q2
$595K Buy
1,903
+61
+3% +$17.9K 0.13% 98
2024
Q1
$524K Buy
1,842
+146
+9% +$42.7K 0.12% 115
2023
Q4
$489K Buy
1,696
+5
+0.3% +$1.36K 0.12% 111
2023
Q3
$454K Buy
1,691
+249
+17% +$62.1K 0.13% 98
2023
Q2
$320K Sell
1,442
-3
-0.2% -$696 0.09% 130
2023
Q1
$349K Sell
1,445
-52
-3% -$12.8K 0.1% 115
2022
Q4
$393K Buy
1,497
+191
+15% +$51.2K 0.13% 109
2022
Q3
$294K Buy
+1,306
New +$317K 0.13% 118
2019
Q4
Sell
-1,037
Closed -$200K 141
2019
Q3
$200K Sell
1,037
-295
-22% -$56.6K 0.1% 132
2019
Q2
$245K Buy
+1,332
New +$239K 0.14% 93

Other funds holding AMGN

Delta Investment Management's AMGN Position: Q1 2026 in Review

Delta Investment Management increased its Amgen (AMGN) stake by 0.12% in Q1 2026, buying an estimated $713 and bringing the position to 1,608 shares worth $566K. The position accounts for 0.1% of the portfolio, ranked #134.

Delta Investment Management first reported a position in AMGN in Q2 2019 and has held it in 17 quarters since. The position peaked at $595K in Q2 2024. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Delta Investment Management held 1,608 shares of Amgen worth $566K as of Q1 2026.
  • Delta Investment Management bought 2 Amgen shares in Q1 2026, an estimated $713.
  • Amgen made up 0.1% of Delta Investment Management's portfolio in Q1 2026, its #134 holding.
  • Delta Investment Management first reported a position in Amgen in Q2 2019 and has held it in 17 quarters since.
  • Delta Investment Management's Amgen position peaked at $595K in Q2 2024.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Delta Investment Management's 13F filing for Q1 2026, filed 13 May 2026.